PRTA logo

Prothena (PRTA) Company Overview

Profile

Full Name:

Prothena Corporation plc

Sector:

Healthcare

Industry:

Biotechnology

Country:

Ireland

IPO:

December 18, 2012

Indexes:

Not included

Description:

Prothena is a biotechnology company focused on developing treatments for neurodegenerative diseases, such as Alzheimer's and Parkinson's. They use innovative science to create therapies that target protein misfolding, aiming to improve patients' lives and address significant medical needs in these areas.

Key Details

Price

$14.14

Annual Revenue

$91.37 M(+69.50% YoY)

Annual EPS

-$2.76(-11.74% YoY)

Annual ROE

-24.85%

Beta

1.80

Events Calendar

Earnings

Next earnings date:

Feb 20, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 7, 25 Oppenheimer
Outperform
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 20, 24 Chardan Capital
Buy
Dec 19, 24 B of A Securities
Neutral
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 1, 24 HC Wainwright & Co.
Buy
Oct 1, 24 B of A Securities
Neutral
Sep 30, 24 Cantor Fitzgerald
Overweight
Aug 14, 24 Oppenheimer
Outperform
Aug 12, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Prothena?
  • Does Prothena pay dividends?
  • What sector is Prothena in?
  • What industry is Prothena in?
  • What country is Prothena based in?
  • When did Prothena go public?
  • Is Prothena in the S&P 500?
  • Is Prothena in the NASDAQ 100?
  • Is Prothena in the Dow Jones?
  • When was Prothena's last earnings report?
  • When does Prothena report earnings?
  • Should I buy Prothena stock now?

What is the ticker symbol for Prothena?

The ticker symbol for Prothena is NASDAQ:PRTA

Does Prothena pay dividends?

No, Prothena does not pay dividends

What sector is Prothena in?

Prothena is in the Healthcare sector

What industry is Prothena in?

Prothena is in the Biotechnology industry

What country is Prothena based in?

Prothena is headquartered in Ireland

When did Prothena go public?

Prothena's initial public offering (IPO) was on December 18, 2012

Is Prothena in the S&P 500?

No, Prothena is not included in the S&P 500 index

Is Prothena in the NASDAQ 100?

No, Prothena is not included in the NASDAQ 100 index

Is Prothena in the Dow Jones?

No, Prothena is not included in the Dow Jones index

When was Prothena's last earnings report?

Prothena's most recent earnings report was on Nov 12, 2024

When does Prothena report earnings?

The next expected earnings date for Prothena is Feb 20, 2025

Should I buy Prothena stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions